fda warning letters glp-1 october 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval FDA Warns Novo Nordisk on

Understanding the underlying mechanisms and potential treatments for this condition is essential for promoting liver health and overall well-being

Skin Brightening The Safer Alternative Unlike harsh whitening products, a professional skin brightening treatment focuses on restoring your skins natural glow without altering its tone

The Active Pharmaceutical Ingredient in the New GLP-1 Weight Loss Pill Fundayo Explained Reading time: 8 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you

Glutathione synthesis ", Biochimica Et Biophysica Acta , 1830 (5), 3143-3153